Evidence map›Paper›PMID 41148121›Full record

ArticleACS applied materials & interfaces2025

pH-Thermo Dual-Responsive Polymeric Nanoparticles for Women's Health: Dual Action Against Cervical and Ovarian Cancer Cells.

Giuseppe Nunziata, Emanuele Limiti, Dania Aramini, Marco Nava, Luca Moretti, Alberto Rainer, Mattia Sponchioni, Filippo Rossi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Giuseppe NunziataDepartment of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milan, Italy.
Emanuele LimitiDepartment of Science and Technology for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, via Álvaro del Portillo 21, 00128 Rome, Italy.
Dania AraminiDepartment of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milan, Italy.
Marco NavaDepartment of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milan, Italy.
Luca MorettiCNR NANOTEC, Istituto di Nanotecnologia, Via Monteroni, 73100 Lecce, Italy.
Alberto RainerCNR NANOTEC, Istituto di Nanotecnologia, Via Monteroni, 73100 Lecce, Italy.
Mattia SponchioniDepartment of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milan, Italy.ORCID 0000-0002-8130-6495
Filippo RossiDepartment of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milan, Italy.ORCID 0000-0003-2665-120X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of smart nanocarriers capable of responding to tumor-specific stimuli represents a promising strategy for improving therapeutic selectivity in oncology. In this work, we present a class of dual-responsive polymeric nanoparticles (NPs) engineered for precision drug delivery in gynecological cancers. Amphiphilic block copolymers of the type P(MAA)-

Indexed as

Antineoplastic AgentsDrug CarriersNanoparticlesOvarian NeoplasmsPolymersUterine Cervical NeoplasmsCell Line, TumorDrug LiberationFemaleFluorouracilHeLa CellsHumansHydrogen-Ion ConcentrationMethacrylatesTemperatureAntineoplastic AgentsDrug CarriersFluorouracilMethacrylatesPolymerscancercolloidsdrug deliverynanoparticlespH-responsivepolymersthermoresponsive

Identifiers

PMID41148121
PMCPMC12616599

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.